Update in Lung Infections and Tuberculosis 2018

Am J Respir Crit Care Med. 2019 Aug 15;200(4):414-422. doi: 10.1164/rccm.201903-0606UP.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antitubercular Agents / therapeutic use*
  • HIV Infections / immunology*
  • Humans
  • Immunocompromised Host / immunology
  • Latent Tuberculosis / diagnosis*
  • Lung / microbiology*
  • Microbiota
  • Mycobacterium avium-intracellulare Infection / drug therapy
  • Pneumococcal Vaccines
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / microbiology
  • Pneumonia, Bacterial / prevention & control
  • Pneumonia, Pneumocystis / immunology
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / immunology

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Pneumococcal Vaccines